Nefropatía asociada a infección por poliomavirus BK

Burgos, D.; Jironda, C.; Martín, M.; González-Molina, M.; Hernández, D.
December 2010
Nefrologia;2010, Vol. 30 Issue 6, p613
Academic Journal
BK polyomavirus (BKV) infection is a problem which is becoming more prominent during kidney transplantation and contributes to chronic rejection of kidney grafts. This means that immunosuppression plays a crucial role when the virus appears in kidney transplant patients. Knowing and understanding the risk factors and closely monitoring the urine and blood serum markers can alleviate undesired effects that are associated with this infection. This review details the clinical and epidemiological aspects of BKV, and the prophylactic and therapeutic methods available to control this virus in kidney transplant patients receiving modern immunosuppression.


Related Articles

  • Polyomavirus Associated Nephropathy after Kidney and Pancreas Transplantation: Case Report.  // Collegium Antropologicum;Jun2010, Vol. 34 Issue 2, p623 

    No abstract available.

  • Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation. Sun, Q; Liu, Z-H; Ji, S; Chen, J; Tang, Z; Zeng, C; Zheng, C; Li, L-S // Kidney International;Jul2006, Vol. 70 Issue 2, p377 

    This study was performed to investigate the clinical and pathologic features of C4d-positive steroid-resistant acute rejection (AR) at different phases after renal transplantation. Fifty-six kidney allograft recipients with C4d-positive AR were divided into three groups, very early rejection...

  • Temporary discontinuation of immunosuppressive treatment and renal graft rejection. Experience of a center in Venezuela. Herrera, José; Chávez, Maribel; Rodríguez-Iturbe, Bernardo // Revista Panamericana de Salud Publica;Nov2006, Vol. 20 Issue 5, p338 

    In some Latin American countries, discontinuation of treatment when immunosuppressive drugs are unavailable can cause late renal graft loss. This retrospective study reports the frequency and consequences of interrupted treatment at a single center in Venezuela. In 2005 and 2006 for more than...

  • DisfuncÅ£ia cronică de grefă, accident sau fatalitate? Bucşa, Cristina Alina; Tacu, Beatrice Dorina; Kerezsy, Eminee; Sinescu, I. // Romanian Journal of Urology;2012, Vol. 11 Issue 4, p10 

    Kidney transplantation is the optimal therapy for the most of the patients with end stage renal disease. One year graft survival was significantly improved in the previous decades, thanks to the new immunosuppressive drugs that had decreased the incidence of acute rejection. However the late...

  • E. Transplantation.  // Kidney;Jan/Feb2004, Vol. 13 Issue 1, p35 

    Presents information on several studies on renal transplantation in 2004. Stability of glomerular filtration rate after transplantation; Immunosuppression for BK virus nephropathy; Allocation of cadaveric organs; Role of antibody-mediated rejection in graft loss and injury.

  • Gazing into a crystal ball to predict kidney transplant outcome. Schröppel, Bernd; Heeger, Peter S.; Schröppel, Bernd // Journal of Clinical Investigation;Jun2010, Vol. 120 Issue 6, p1803 

    Kidney transplantation is the optimal therapy for end-stage kidney disease but requires lifelong immunosuppression. Despite improvements in immunosuppression regimens that have reduced rates of acute transplant rejection, long-term allograft survival remains suboptimal. More than 50% of...

  • High-Dose MMF Reduces Acute Rejection in African-Americans.  // Kidney;May/Jun98, Vol. 7 Issue 3, p125 

    Discusses the abstract of the research paper 'Immunosuppressive therapy in high-risk transplant patients,' by J.F. Neylan for the United States Transplant Mycophenolate Mofetil Study Group and published in a 1997 issue of the journal 'Transplantation.'

  • Common medications prescribed for transplantation patients. Coleman, Adrian // Journal of Renal Nursing;Sep2013, Vol. 5 Issue 5, p222 

    Organ rejection is a major barrier to renal transplantation and the cost of immunosuppressants used for maintenance has been estimated at around £5000 per patient per year. In this article, pharmacist Adrian Coleman defines three classes of immunosuppressant medication, their mechanisms of...

  • Antithymocyte Globulin (Rabbit): A Review of the Use of Thymoglobulin in the Prevention and Treatment of Acute Renal Allograft Rejection. Ormrod, D.; Jarvis, B. // BioDrugs;2000, Vol. 14 Issue 4, p255 

    The role of Thymoglobulin (TMG), a polyclonal rabbit-derived antithymocyte globulin, in the prevention and treatment of acute renal allograft rejection is the focus of this review. TMG and the polyclonal horse-derived antithymocyte globulin Atgam (ATG) have been compared in a multicentre...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics